Context:

Farmalabor srl aims at developing an innovative platform for the production of3D/4D printed formulations as personalized medicines (ForMe), considering the specific requirements of each patient in terms of pathology, age, weight, metabolism, gender, etc.

The challenge:

The interindividual variability is an increasing global problem when treating patients from different backgrounds with diverse age, weight, comorbidities, customs, metabolism, and necessities. Dose adjustment is frequently based on empirical methods, and therefore, the chance of undesirable side effects to occur is high.

• Adherence of the 3D printed drugs with the appropriate legal framework.
• Accurate dosing of 3D printed drugs.

Supplier:

https://www.farmalabor.it/